Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Seline E. Miller Insider Profile
4 Followers
Seline E. Miller, SVP Finance; Interim CFO & PAO at Gyre Therapeutics, holds 0.00 shares in Gyre Therapeutics (Ticker: GYRE).
Seline E. Miller has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Seline E. Miller does not currently own shares as a corporate insider.
A breakdown of Seline E. Miller's holdings
Insider Roles
SVP Finance; Interim CFO & PAO
Roles that Seline E. Miller holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Seline E. Miller
Seline E. Miller's Trading History
List of latest transactions for each holding click on a transaction to see Seline E. Miller's performance on stock
You May Also Like
Seline E. Miller insider profile FAQ
What is the percentage of profitable transactions made by Seline E. Miller?
The percentage of profitable transactions made by Seline E. Miller is ―.
What is the average return per transaction made by Seline E. Miller?
The average return per transaction made by Seline E. Miller is ―.
What stocks does Seline E. Miller hold?
Seline E. Miller holds: GYRE stocks.
What was Seline E. Miller’s latest transaction?
Seline E. Miller latest transaction was an Uninformative Sell of ―.
What was Seline E. Miller's most profitable transaction?
Seline E. Miller’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Seline E. Miller's role in Gyre Therapeutics?
Seline E. Miller's role in Gyre Therapeutics is SVP Finance; Interim CFO & PAO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.